With reports of Alex Bregman signing a three-year deal with the Red Sox, Thursday is a great day for Boston baseball.

The FDA on Wednesday approved the industry’s first-ever tablet treatment for spinal muscular atrophy— Roche ’s SMN2 splicing ...

A $30,000 scholarship programme will be launched alongside internship opportunities for science graduates as Roche Bermuda ...

Helmed by Roche alums, Newleos Therapeutics is taking over four drugs dropped from the Swiss pharma’s pipeline in early 2024.

Patrick Roche also informed a receptionist that "12pm is not the f**king morning" before his gym membership was cancelled due ...

While I certainly can't stand the cold or snow, I always seem to be the person saying, "oh this isn't bad," or "this is barely any snow." I know it stems from my upbringing in Wisconsin and my ...

Evrysdi is a non-invasive, disease-modifying option that can be swallowed whole or dispersed in water for patients with ...

Over the past nine years, patients with spinal muscular atrophy have seen the number of FDA-approved treatment options for ...

Roche Holding AG’s US unit removed diversity and inclusion targets from its website, the latest in a series of publicly ...

Newleos Therapeutics emerged Thursday with $93.5 million and a bundle of oral small molecules that it licensed from Roche, ...

UBS upgraded Roche (RHHBY) to Buy from Neutral with a price target of CHF 338, up from CHF 300. The company offers sustainable growth with ...

Newleos Therapeutics is making its debut with $93.5 million aimed at developing safer and more effective neuroscience treatments with several clinical programs from Swiss major Roche in hand. | ...